HOME >> BIOLOGY >> NEWS
NAFTA arbitrators in environmental case agree to formal public input, a first for trade hearings

The decision by a NAFTA tribunal to accept and formally consider public submissions in a major environmental case represents a precedent-setting "triumph for openness" in international trade and investment arbitration, says the Canadian-based International Institute for Sustainable Development.

IISD has won a 3 year battle to take part in NAFTA hearings this year into claims by Methanex Corporation that California violated guarantees of investors' rights when it banned a polluting gasoline additive manufactured in Canada. Methanex, of British Columbia, says its NAFTA Chapter 11 rights were violated when the state banned MTBE, a suspected carcinogen.

The breakthrough, communicated to IISD late Friday, was welcomed by the Institute's President David Runnalls as another new breach in the walls that have surrounded international trade and investment arbitration cases, until now conducted secretly "in-camera" with investors and governments as the sole participants.

Said Mr. Runnalls: "We set out in August 2000 to address the procedural deficiencies of the investor-state arbitrations, as well as concerns about rights accorded to investors under NAFTA's Chapter 11. This precedent-setting Tribunal decision builds on previous breakthroughs that opened the hearings to the public, thus making the process more transparent. Now the hearings are open for public input as well. The decision addresses almost all of our original procedural goals and we welcome this news.

"We look forward now to participating in the process of getting the interpretations of NAFTA's Chapter 11 right. Foreign investment is critical to achieving sustainable development today. But foreign investor rights that take priority over the right of policy-makers to govern and legislate in the area of sustainable development are self-defeating.

"Our goal is to leave the Tribunal with a strong and clear impression of what is at stake, and how appropriate interpretatio
'"/>

Contact: Terry Collins
collins1@sympatico.ca
416-538-8712
International Institute for Sustainable Development
2-Feb-2004


Page: 1 2 3 4

Related biology news :

1. Research suggests unborn children may be at risk from environmental pollution
2. Will a reduction in military spending improve our environmental future?
3. 8 environmental stewards win $900,000 in biodiversity awards
4. Chemical Society announces EPA awards for environmentally friendly technology
5. Is that plant a tortoise or a hare? Answer predicts its response to environmental change
6. Ancient Greeks help scientists build environmentally friendly nano devices
7. Comprehensive study: We know little about environmental effects on kids
8. Geoenvironmental researchers to join Technium
9. New environmental journalism website holds more than 700 articles in three languages
10. Viruses may be environmentally friendly decontaminants
11. UN study shows environmental consequences from ongoing boom in personal computer sales

Post Your Comments:
(Date:2/24/2015)... DUBLIN , Feb. 24, 2015 Research ... announced the addition of the "Global 2D ... offering. The analysts forecast the ... a CAGR of 32.12% over the period 2014-2019 ... devices in non-traditional sectors is one of the ...
(Date:2/13/2015)... -- ACT Genomics Co., Ltd., a cancer molecular ... genomic information into precision diagnosis and personalized treatments, ... million in the its first private funding round. ... , ACT Genomics has developed comprehensive cancer ... implement next generation sequencing (NGS) and multiplex molecular ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
(Date:2/27/2015)... 2015 A paper published today, " ... " in Science Translational Medicine, demonstrates ... reduce the risk associated with investing in the ... levels of funding for developing so-called "orphan" drugs. ... collaboration between scientists at the National Center for ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
Cached News: